197 related articles for article (PubMed ID: 8311114)
41. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
[TBL] [Abstract][Full Text] [Related]
42. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
43. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.
Mao L; Hruban RH; Boyle JO; Tockman M; Sidransky D
Cancer Res; 1994 Apr; 54(7):1634-7. PubMed ID: 8137272
[TBL] [Abstract][Full Text] [Related]
44. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
45. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
46. [Molecular changes in adenocarcinoma of the small intestine associated with Peutz-Jeghers syndrome].
Hidalgo L; Villanueva A; Soler T; Matías Guiu X; Capellá G
Rev Esp Enferm Dig; 1996 Feb; 88(2):137-40. PubMed ID: 8664070
[TBL] [Abstract][Full Text] [Related]
47. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL
Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999
[TBL] [Abstract][Full Text] [Related]
48. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
49. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
50. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
[TBL] [Abstract][Full Text] [Related]
51. Sex differences in clinicopathological features of peripheral T1 adenocarcinoma of the lung.
Lima CE; Mizushima Y; Kashii T; Matsui K; Noto H; Miwa A; Kobayashi M; Kitagawa M
Anticancer Res; 1994; 14(2B):721-3. PubMed ID: 8010732
[TBL] [Abstract][Full Text] [Related]
52. A correlation between mutation of the p53 gene and histological heterogeneity in differentiated adenocarcinomas of the lung, with reference to stepwise progression and metastatic ability.
Yoshida Y
Hiroshima J Med Sci; 1994 Mar; 43(1):13-21. PubMed ID: 8014071
[TBL] [Abstract][Full Text] [Related]
53. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.
Redston MS; Caldas C; Seymour AB; Hruban RH; da Costa L; Yeo CJ; Kern SE
Cancer Res; 1994 Jun; 54(11):3025-33. PubMed ID: 8187092
[TBL] [Abstract][Full Text] [Related]
54. Different site mutation of the K-ras gene in a patient with metachronous double lung cancers.
Sugio K; Inoue T; Inoue K; Yaita H; Inuzuka S; Ishida T; Sugimachi K
Anticancer Res; 1993; 13(6B):2469-71. PubMed ID: 8135484
[TBL] [Abstract][Full Text] [Related]
55. Molecular comparison of human and mouse pulmonary adenocarcinomas.
Malkinson AM
Exp Lung Res; 1998; 24(4):541-55. PubMed ID: 9659582
[TBL] [Abstract][Full Text] [Related]
56. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung.
Kashii T; Mizushima Y; Nakagawa K; Monno S; Yano S
Anticancer Res; 1992; 12(3):621-4. PubMed ID: 1622116
[TBL] [Abstract][Full Text] [Related]
57. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
58. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
[TBL] [Abstract][Full Text] [Related]
59. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
60. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
